Project Details
Description
This is a ERANET funded clinical study to identify predictive markers for ketamine treatment.
| Short title | NEUROMARKET |
|---|---|
| Status | Finished |
| Effective start/end date | 01/04/20 → 31/12/24 |
Funding
- Research Council of Finland
Neuroimaging and blood markers as indicators of ketamine efficacy in treatment resistant depression
- Coffey, Eleanor (Principal Investigator)
- Walter, Martin (Co-Principal Investigator)
- Sartorius, Alexander (Principal Investigator)
- Lecourtier, Lucas (Principal Investigator)